Edition:
United Kingdom

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

55.81USD
7:39pm BST
Change (% chg)

$0.60 (+1.09%)
Prev Close
$55.21
Open
$55.01
Day's High
$56.09
Day's Low
$55.01
Volume
69,057
Avg. Vol
229,180
52-wk High
$81.48
52-wk Low
$44.62

Chart for

About

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $2,893.28
Shares Outstanding(Mil.): 50.80
Dividend: --
Yield (%): --

Financials

  NUVA.OQ Industry Sector
P/E (TTM): 91.50 32.19 32.75
EPS (TTM): 0.62 -- --
ROI: 2.56 13.89 14.38
ROE: 5.03 16.72 16.07

BRIEF-NuVasive Reports Q1 GAAP Loss Per Share Of $0.53

* FY2018 REVENUE VIEW $1.10 BILLION -- THOMSON REUTERS I/B/E/S

01 May 2018

BRIEF-Nuvasive Posts Q4 Adj. Earnings Per Share $0.56

* NUVASIVE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

26 Feb 2018

BRIEF-John DeFord To Join NuVasive Board Of Directors

* NUVASIVE INC - AS A RESULT OF DEFORD'S APPOINTMENT, NUVASIVE BOARD OF DIRECTORS CONSISTS OF 10 DIRECTORS Source text for Eikon: Further company coverage:

08 Feb 2018

BRIEF-NuVasive Comments On Expected Impact Of U.S. Tax Reform

* NUVASIVE INC - ‍SAVINGS FROM TAX REFORM EXPECTED TO BOOST FORWARD-LOOKING FREE CASH FLOW, NON-GAAP EPS IN EXCESS OF 10 % PER YEAR BEGINNING IN 2018​

21 Dec 2017

Earnings vs. Estimates